Antidepressant use during pregnancy and the risk of pregnancy‐induced hypertension
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Antidepressants represent one of the most commonly used medications during pregnancy. • There is a scarcity of information on impact of medications on maternal health outcomes. • As the primary caregiver of the child, the mother's health and well‐being should carry significant weight when making decisions regarding medication use during pregnancy. WHAT THIS STUDY ADDS • Antidepressant use during pregnancy is associated with increased risk of pregnancy‐induced hypertension. • These findings highlight the importance of further research evaluating the impact of gestational medication use on the health of the mother. AIM Due to their effect on altering physiological interactions between vasodilator and vasoconstrictor autacoids in normal pregnancies, antidepressants may be associated with the risk of pregnancy‐induced hypertension. We evaluated the impact of antidepressant use during pregnancy on the risk of pregnancy‐induced hypertension. METHODS We conducted a nested case–control study within the Quebec Pregnancy Registry, built by linkage of provincial medical, pharmaceutical, hospital and birth databases. We identified 1216 women with a diagnosis of pregnancy‐induced hypertension with or without pre‐eclampsia and with no history of hypertension before pregnancy. We randomly selected 10 controls for each case, matched on case index date (date of diagnosis) and gestational age. Odds ratios (OR) were calculated using conditional logistic regression models, adjusting for sociodemographic characteristics, maternal depression, anxiety, other chronic conditions, medication use and health service utilization. RESULTS Among cases, 45 (3.7%) had used antidepressants during pregnancy compared with 300 (2.5%) in the control group (OR 1.52, 95% CI 1.10, 2.09). After adjusting for potential confounders, use of antidepressants during pregnancy was significantly associated with increased risk of pregnancy‐induced hypertension (OR 1.53, 95% CI 1.01, 2.33). In stratified analyses, use of selective serotonin re‐uptake inhibitors (OR 1.60, 95% CI 1.00, 2.55), and more specifically, paroxetine (OR 1.81, 95% CI 1.02, 3.23) was associated with risk of pregnancy‐induced hypertension. CONCLUSIONS Women who use antidepressants during pregnancy are at increased risk of pregnancy‐induced hypertension with or without pre‐eclampsia above and beyond the risk that could be attributed to their depression or anxiety disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725
Depression and anxiety in early pregnancy and risk for preeclampsia
Kurki, T. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(99)00602-x · Cited by 690
Tamblyn, R., Lavoie, G., Petrella, L., & Monette, J. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00234-h · Cited by 577
Ros, H. S., Cnattingius, S., & Lipworth, L. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009400 · Cited by 401
Mortality in a cohort of street youth in Montreal
Roy, É. (2004) · JAMA · doi:10.1001/jama.292.5.569 · Cited by 334
Thase, M. E. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1002 · Cited by 331
Depression during Pregnancy: Overview of Clinical Factors
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Clinical Drug Investigation · doi:10.2165/00044011-200424030-00004 · Cited by 317
The nested case-control study in cardiology
Essebag, V., Genest, J., Suissa, S., & Pilote, L. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00512-x · Cited by 173
Cited by
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Antidepressant use during pregnancy and the risk of autism spectrum disorder in children
Boukhris, T., Sheehy, O., Mottron, L., & Bérard, A. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.3356 · Cited by 297
“Gestational exposure to ADs has been associated with an increased risk of spontaneous abortion,(3)majorcongenitalmalformations,(4)prematurity,(5,6) low birth weight,(5,6) neonatal withdrawal,(7) and pregnancyinduced hypertension.(8) Discontinuation of ADs during pregnancy in women with severe depression was associated…”
BackgroundSelf-citationVigod, S. N., Wilson, C. A., & Howard, L. M. (2016) · BMJ · doi:10.1136/bmj.i1547 · Cited by 148
Eleftheriou, G., Zandonella Callegher, R., Butera, R., De Santis, M., Cavaliere, A. F., Vecchio, S., Pistelli, A., Mangili, G., Bondi, E., Somaini, L., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20166565 · Cited by 17
Molenaar, N. M., Brouwer, M. E., Duvekot, J. J., Burger, H., Knijff, E. M., Hoogendijk, W. J., Bockting, C. L. H., de Wolf, G. S., & Lambregtse-van den Berg, M. P. (2018) · Midwifery · doi:10.1016/j.midw.2018.02.018 · Cited by 14
Metadata
- Authors
- De Vera, M. A., & Bérard, A.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2012-07-10
- Volume
- 74
- Issue
- 2
- Pages
- 362-369
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1776388298
- Cited by
- 69
- References
- 8
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant use during pregnancy and the risk of pregnancy‐induced hypertension. https://app.cochat.ai/papers/10.1111/j.1365-2125.2012.04196.x
- The paper
- De Vera, M. A., & Bérard, A. (2012). Antidepressant use during pregnancy and the risk of pregnancy‐induced hypertension. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2012.04196.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.